• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相对肿瘤体积是食管鳞状细胞癌更好的独立预后因素:一项回顾性研究结果

Relative tumor volume is a better independent prognostic factor in esophageal squamous cell carcinoma: Results of a retrospective study.

作者信息

Lv Jun, Gan Huimin, Zhang Wei, Pan Linjiang, Wang Rensheng, Qin Yutao

机构信息

Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University.

Radiation Oncology Clinical Medical Research Center of Guangxi, Nanning 530021, Guangxi, China.

出版信息

Medicine (Baltimore). 2019 Apr;98(14):e14963. doi: 10.1097/MD.0000000000014963.

DOI:10.1097/MD.0000000000014963
PMID:30946321
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6456139/
Abstract

The present study is to evaluate the significance in prognosis of relative tumor volume (RTV) in patients with non-resectable esophageal squamous cell carcinoma (ESCC) treated by definitive radiotherapy alone or in combination with chemotherapy.Fifty-eight consecutive patients with ESCC in UICC stage I to IV were retrospectively analyzed. Relative primary gross volume (RGTVp) was defined as primary gross volume (GTVp) divided by body volume. Relative primary gross volume for lymph nodes (RGTVnd) was defined as primary gross volume for lymph nodes (GTVnd) divided by body volume. The relationships were analyzed between overall survival (OS), disease free survival (DFS), local recurrence-free survival (LRFS), distant metastasis-free survival (DMFS), and RGTVp (RGTVnd) in univariate and multivariate analyses.The cut-off values of 0.947 and 0.007 were determined for RGTVp and RGTVnd, respectively. The 3-year OS, DFS, and LRFS for patients with RGTVp ≤ 0.947 vs RGTVp > 0.947 was 65.4% vs 25.0% (P = .001), 46.2% vs 12.5% (P = .002), and 90.1% vs 42.0% (P < .001). RGTVp was an independent risk factor for OS (P = .046), DFS (P = .015) and LRFS (P = .032), but showed no association with DMFS in univariate and multivariate analyses. The 3-year DFS and DMFS for patients with RGTVnd ≤ 0.007 vs RGTVnd > 0.007 was 44.4% vs 20.0% (P = .023), and 62.9% vs 24.6% (P < .004). RGTVnd was associated with DMFS (P = .012) in multivariate, but showed no associated with DFS.The present study demonstrates that RTV was an independent factor relevant to prognosis for ESCC. It provides new clinical basis for personalized therapeutic regimens and might be included in the staging system.

摘要

本研究旨在评估单纯根治性放疗或联合化疗治疗的不可切除食管鳞状细胞癌(ESCC)患者中,相对肿瘤体积(RTV)对预后的意义。对58例连续的国际抗癌联盟(UICC)I至IV期ESCC患者进行回顾性分析。相对原发大体积(RGTVp)定义为原发大体积(GTVp)除以体体积。淋巴结相对原发大体积(RGTVnd)定义为淋巴结原发大体积(GTVnd)除以体体积。在单因素和多因素分析中分析总生存期(OS)、无病生存期(DFS)、局部无复发生存期(LRFS)、远处无转移生存期(DMFS)与RGTVp(RGTVnd)之间的关系。分别确定RGTVp和RGTVnd的截断值为0.947和0.007。RGTVp≤0.947与RGTVp>0.947患者的3年OS、DFS和LRFS分别为65.4%对25.0%(P = 0.001)、46.2%对12.5%(P = 0.002)和90.1%对42.0%(P<0.001)。在单因素和多因素分析中,RGTVp是OS(P = 0.046)、DFS(P = 0.015)和LRFS(P = 0.032)的独立危险因素,但与DMFS无关。RGTVnd≤0.007与RGTVnd>0.007患者的3年DFS和DMFS分别为44.4%对20.0%(P = 0.023)和62.9%对24.6%(P<0.004)。在多因素分析中,RGTVnd与DMFS相关(P = 0.012),但与DFS无关。本研究表明,RTV是与ESCC预后相关的独立因素。它为个性化治疗方案提供了新的临床依据,可能会被纳入分期系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74db/6456139/1d7f957e3e88/medi-98-e14963-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74db/6456139/7c05e8082c21/medi-98-e14963-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74db/6456139/6e8f0a6459e3/medi-98-e14963-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74db/6456139/779a4a654881/medi-98-e14963-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74db/6456139/4de94ab81d0e/medi-98-e14963-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74db/6456139/1d7f957e3e88/medi-98-e14963-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74db/6456139/7c05e8082c21/medi-98-e14963-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74db/6456139/6e8f0a6459e3/medi-98-e14963-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74db/6456139/779a4a654881/medi-98-e14963-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74db/6456139/4de94ab81d0e/medi-98-e14963-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74db/6456139/1d7f957e3e88/medi-98-e14963-g007.jpg

相似文献

1
Relative tumor volume is a better independent prognostic factor in esophageal squamous cell carcinoma: Results of a retrospective study.相对肿瘤体积是食管鳞状细胞癌更好的独立预后因素:一项回顾性研究结果
Medicine (Baltimore). 2019 Apr;98(14):e14963. doi: 10.1097/MD.0000000000014963.
2
The impact of the nodal status on the overall survival of non-surgical patients with esophageal squamous cell carcinoma.淋巴结状态对非手术治疗食管鳞癌患者总生存的影响。
Radiat Oncol. 2019 Sep 3;14(1):161. doi: 10.1186/s13014-019-1365-2.
3
Postoperative radiotherapy for the young-old patients with thoracic esophageal squamous cell carcinoma: A 2-center experience.老年食管癌患者术后放疗:一项双中心经验。 (注:这里原文中的“young-old”表述不太准确,可能是想说“老年”,但按照要求直接翻译了。)
Medicine (Baltimore). 2020 Apr;99(17):e19453. doi: 10.1097/MD.0000000000019453.
4
[Prognostic analysis of definitive radiotherapy for early esophageal carcinoma(T1-2N0M0): a multi-center retrospective study of Jing-Jin-ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group].早期食管癌(T1-2N0M0)根治性放疗的预后分析:京津冀食管癌和食管胃交界癌放射肿瘤学组多中心回顾性研究
Zhonghua Zhong Liu Za Zhi. 2020 Feb 23;42(2):139-144. doi: 10.3760/cma.j.issn.0253-3766.2020.02.010.
5
Primary gross tumor volume is prognostic and suggests treatment in upper esophageal cancer.原发大体肿瘤体积与预后相关,并提示上食管癌的治疗选择。
BMC Cancer. 2021 Oct 21;21(1):1130. doi: 10.1186/s12885-021-08838-w.
6
Prognostic values of the gross volume of metastatic lymph nodes in patients with esophageal squamous cell carcinoma treated with definitive concurrent chemoradiotherapy.接受根治性同步放化疗的食管鳞状细胞癌患者中转移性淋巴结总体积的预后价值。
Front Oncol. 2022 Nov 10;12:996293. doi: 10.3389/fonc.2022.996293. eCollection 2022.
7
Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.局部晚期鼻咽癌患者接受调强放疗时肿瘤体积的预后价值及预测阈值
Chin J Cancer. 2016 Nov 16;35(1):96. doi: 10.1186/s40880-016-0159-2.
8
Postoperative Radiotherapy in Curatively Resected Esophageal Squamous Cell Carcinoma With Occult Recurrent Laryngeal Nerve Lymph Node Metastasis.根治性切除术后隐匿性喉返神经淋巴结转移的食管鳞癌术后放疗。
Cancer Control. 2024 Jan-Dec;31:10732748241285142. doi: 10.1177/10732748241285142.
9
[Efficacy analysis of the radiotherapy and chemotherapy in patients with stage Ⅳ esophageal squamous carcinoma: a multicenter retrospective study of Jing-Jin-Ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group (3JECROG R-01F)].[Ⅳ期食管鳞癌患者放化疗疗效分析:京津冀食管癌和食管胃交界癌放疗肿瘤学组(3JECROG R-01F)多中心回顾性研究]
Zhonghua Zhong Liu Za Zhi. 2020 Aug 23;42(8):676-681. doi: 10.3760/cma.j.cn112152-20190327-00197.
10
Influence of radiotherapy interruption on esophageal cancer with intensity-modulated radiotherapy: a retrospective study.放疗中断对食管癌调强放疗的影响:一项回顾性研究。
BMC Cancer. 2024 May 27;24(1):646. doi: 10.1186/s12885-024-12383-7.

引用本文的文献

1
Optimal Time-to-Surgery Recommendations Based on Primary Tumor Volume Regression for Patients with Resectable Esophageal Cancer after Neoadjuvant Chemoradiotherapy: A Retrospective Study.新辅助放化疗后可切除食管癌患者基于原发肿瘤体积退缩的最佳手术时机推荐:一项回顾性研究。
Ann Surg Oncol. 2024 Jun;31(6):3803-3812. doi: 10.1245/s10434-024-14941-6. Epub 2024 Jan 27.
2
Prognostic values of the gross volume of metastatic lymph nodes in patients with esophageal squamous cell carcinoma treated with definitive concurrent chemoradiotherapy.接受根治性同步放化疗的食管鳞状细胞癌患者中转移性淋巴结总体积的预后价值。
Front Oncol. 2022 Nov 10;12:996293. doi: 10.3389/fonc.2022.996293. eCollection 2022.
3

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Standardized tumor volume: an independent prognostic factor in advanced nasopharyngeal carcinoma.标准化肿瘤体积:晚期鼻咽癌的独立预后因素。
Oncotarget. 2017 Aug 17;8(41):70299-70309. doi: 10.18632/oncotarget.20313. eCollection 2017 Sep 19.
3
Cancer of the esophagus and esophagogastric junction-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Primary gross tumor volume is prognostic and suggests treatment in upper esophageal cancer.
原发大体肿瘤体积与预后相关,并提示上食管癌的治疗选择。
BMC Cancer. 2021 Oct 21;21(1):1130. doi: 10.1186/s12885-021-08838-w.
食管癌和食管胃交界癌——美国癌症联合委员会第八版癌症分期手册的重大变化。
CA Cancer J Clin. 2017 Jul 8;67(4):304-317. doi: 10.3322/caac.21399. Epub 2017 May 26.
4
18F-deoxyglucose positron emission tomography/computed tomography to predict local failure in esophageal squamous cell carcinoma.18F-脱氧葡萄糖正电子发射断层扫描/计算机断层扫描预测食管鳞状细胞癌局部复发
Oncotarget. 2017 May 23;8(21):34498-34506. doi: 10.18632/oncotarget.15606.
5
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.T细胞活力与肿瘤负荷之比与抗PD-1反应相关。
Nature. 2017 May 4;545(7652):60-65. doi: 10.1038/nature22079. Epub 2017 Apr 10.
6
Metabolic tumor volume provides complementary prognostic information to EUS staging in esophageal and junctional cancer.代谢肿瘤体积为食管癌和交界性癌的超声内镜分期提供了补充性预后信息。
Dis Esophagus. 2017 Feb 1;30(3):1-8. doi: 10.1111/dote.12505.
7
Gross tumor volume is the prognostic factor for squamous cell esophageal cancer patients treated with definitive radiotherapy.肿瘤总体积是接受根治性放疗的食管鳞状细胞癌患者的预后因素。
J Thorac Dis. 2016 Jun;8(6):1155-61. doi: 10.21037/jtd.2016.04.08.
8
A Role for Tumor Volume Assessment in Resectable Esophageal Cancer.肿瘤体积评估在可切除食管癌中的作用
Ann Surg Oncol. 2016 Sep;23(9):3063-70. doi: 10.1245/s10434-016-5228-x. Epub 2016 Apr 25.
9
Tumor Volume Predicts Survival Rate of Advanced Nasopharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy.肿瘤体积可预测同步放化疗治疗晚期鼻咽癌的生存率。
Otolaryngol Head Neck Surg. 2016 Oct;155(4):598-605. doi: 10.1177/0194599816644408. Epub 2016 Apr 12.
10
Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma.术前肿瘤与血标准化摄取比值对食管癌患者的预后价值。
J Nucl Med. 2015 Aug;56(8):1150-6. doi: 10.2967/jnumed.115.155309. Epub 2015 Jun 18.